Wira Noviana SUHERY, Yeyet Cahyati SUMIRTAPURA, Jessie Sofia PAMUDJI, Diky MUDHAKIR

Development and characterization of self-nanoemulsifying drug delivery system (SNEDDS) formulation for enhancing dissolution of fenofibric acid

Fenofibric acid is an active form of fenofibrate and a poorly water-soluble drug. The study aims to formulate and characterize self-nanoemulsifying drug delivery system (SNEDDS) to improve the dissolution of fenofibric acid. The selection of oil, surfactant, and cosurfactant for preliminary screening was determined by the solubility study of fenofibric acid in various vehicles. The composition of selected oil, surfactant, and cosurfactant was glyceryl monolinoleate (Maisine® CC), Kolliphor® RH 40, and Transcutol® HP, PEG 400 respectively. The study results showed that the best SNEDDS formulation was Fd with a ratio of oil, surfactant, and cosurfactant of 10:70:20 % v/v/v (Maisine® CC: Kolliphor® RH 40: Transcutol® HP). It produced good self-nanoemulsifying drug delivery system such as the droplet size was 15.30 nm, 99.27 % transmittance, thermodynamically stable, self-emulsification time was 18.84 seconds, the morphology of the formed nanoemulsion droplets was observed as sphere-shaped droplets and 1.6 fold increase in the dissolution of fenofibric acid.

PDF

___

[1] Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res. 2005; 22(1): 11-23. [CrossRef]
[2] Takano R, Furumoto K, Shiraki K, Takata N, Hayashi Y, Aso Y, Yamashita S. Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation. Pharm Res. 2008; 25(10): 2334-2344. [CrossRef]
[3] Bohr A, Kristensen J, Stride E, Dyas M, Edirisinghe M. Preparation of microspheres containing low solubility drug compound by electrohydrodynamic spraying. Int J Pharm. 2011; 412(1-2): 59-67. [CrossRef]
[4] Lipinski CALF. Poor aqueous solubility—an industry wide problem in drug discovery. Am Pharm Rev. 2002; 5(3): 82-85.
[5] Ong SGM, Ming LC, Lee KS, Yuen KH. Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes. Pharmaceutics. 2016; 8(3): 25. [CrossRef]
[6] Pauli G, Tang WL, Li SD. Development and characterization of the solvent-assisted active loading technology (SALT) for liposomal loading of poorly water-soluble compounds. Pharmaceutics. 2019; 11(9): 465. [CrossRef]
[7] Yasmin R, Rao S, Bremmell KE, Prestidge CA. Porous silica-supported solid lipid particles for enhanced solubilization of poorly soluble drugs. The AAPS J. 2016: 18(4): 876-885. [CrossRef]
[8] Kumar R, Singh A, Sharma K, Dhasmana D, Garg N, Siril PF. Preparation, characterization and in vitro cytotoxicity of fenofibrate and nabumetone loaded solid lipid nanoparticles. Mater Sci Eng C. 2020; 106: 110-184. [CrossRef]
[9] Mishra A, Imam SS, Aqil M, Ahad A, Sultana Y, Ameeduzzafar, Ali A. Carvedilol nano lipid carriers: formulation, characterization and in-vivo evaluation. Drug Deliv. 2016; 23(4): 1486-1494. [CrossRef]
[10] Choi KO, Choe J, Suh S, Ko S. Positively charged nanostructured lipid carriers and their effect on the dissolution of poorly soluble drugs. Molecules. 2016; 21(5): 672. [CrossRef]
[11] Li H, Pan T, Cui Y, Li X, Gao J, Yang W, Shen S. Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique. Int J Nanomedicine. 2016; 11: 3777. [CrossRef]
[12] Wik J, Bansal KK, Assmuth T, Rosling A, Rosenholm JM. Facile methodology of nanoemulsion preparation using oily polymer for the delivery of poorly soluble drugs. Drug Deliv Transl Res. 2019: 1-13. [CrossRef]
[13] Kamble RN, Mehta PP, Kumar A. Efavirenz self-nano-emulsifying drug delivery system: in vitro and in vivo evaluation. AAPS Pharm Sci Tech. 2016; 17(5): 1240-1247. [CrossRef]
[14] Senapati PC, Sahoo SK, Sahu AN. Mixed surfactant based (SNEDDS) self-nanoemulsifying drug delivery system presenting efavirenz for enhancement of oral bioavailability. Biomed Pharmacother. 2016; 80: 42-51. [CrossRef]
[15] Kassem AA, Mohsen AM, Ahmed RS, Essam TM. Self-nanoemulsifying drug delivery system (SNEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: Design, optimization, in vitro and in vivo evaluation. J Mol Liq. 2016; 218: 219-232. [CrossRef]
[16] Kim RM, Jang DJ, Kim YC, Yoon JH, Min KA, Maeng HJ, Cho KH. Flurbiprofen-loaded solid SNEDDS preconcentrate for the enhanced solubility, in-vitro dissolution and bioavailability in rats. Pharmaceutics. 2018; 10(4): 247. [CrossRef]
[17] Kanwal T, Kawish M, Maharjan R, Shah MR, et al. Design and development of permeation enhancer containing selfnanoemulsifying drug delivery system (SNEDDS) for ceftriaxone sodium improved oral pharmacokinetics. J Mol Liq. 2019; 289: 111098. [CrossRef]
[18] Balakumar K, Raghavan CV, Abdu S. Self-nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability, and pharmacokinetic evaluation. Colloids Surf B. 2013; 112: 337-343. [CrossRef]
[19] Syukri Y, Martien R, Lukitaningsih E, Nugroho AE. Novel self-nanoemulsifying drug delivery system (SNEDDS) of andrographolide isolated from Andrographis paniculata Ness: characterization, in-vitro and in-vivo assessment. J Drug Deliv Sci Tech. 2018; 47: 514-520. [CrossRef]
[20] Porter C, Trevaskis N, Charman W. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007; 6: 231-248. [CrossRef]
[21] Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006; 29(3-4): 278-287. [CrossRef]
[22] Weerapol Y, Limmatvapirat S, Sriamornsak P. Effect of Lipophilicity of Drugs on Dissolution Profiles of Selfnanoemulsifying Drug Delivery System. In Adv Mat Res. Trans Tech Publications Ltd. 2015; 1060: 37-40. [CrossRef]
[23] Windriyati YN, Sumirtapura YC, Pamudji JS. Dissolution enhancement and physicochemical characterization of fenofibric acid in surface solid dispersion with croscarmellose sodium. J Res Pharm. 2019; 23(2): 315-325. [CrossRef]
[24] Moutzouri E, Kei A, Elisaf MS, Milionis HJ. Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid. Vasc Health Risk Manag. 2010; 6: 525-539. [CrossRef]
[25] Rath NP, Haq W, Balendiran GK. Fenofibric acid. Acta Cryst C: Crystal Structure Communications. 2005; 61(2): o81-o84.
[26] Yousaf AM, Ramzan M, Shahzad Y, Mahmood T, Jamshaid M. Fabrication and in vitro characterization of fenofibric acid-loaded hyaluronic acid–polyethylene glycol polymeric composites with enhanced drug solubility and dissolution rate. Int J Polym Mater. 2019; 68(9): 510-5. [CrossRef]
[27] Salem HF, Kharshoum RM, Halawa AKA, Naguib DM. Preparation and optimization of tablets containing a selfnanoemulsifying drug delivery system loaded with rosuvastatin. J Liposome Res. 2018; 28(2):149-160. [CrossRef]
[28] Chatterjee B, Hamed AS, Ahmed MAA, Mandal UK, Sengupta P. Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view. Drug Deliv. 2016; 23(9): 3639-3652. [CrossRef]
[29] BASF. Technical information Kolliphor ® RH 40. https://products.basf.com/documents/pim;save/en/8952336787925.Technical%20Information.pdf (accessed on 2 March 2020).
[30] Nasr A, Gardouh A, Ghorab M. Novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of olmesartan medoxomil: design, formulation, pharmacokinetic and bioavailability evaluation. Pharmaceutics. 2016; 8(3), 20. [CrossRef]
[31] Agrawal AG, Kumar A, Gide PS. Formulation of solid self- nanoemulsifying drug delivery systems using N-methyl pyrrolidone as cosolvent. Drug Dev Ind Pharm. 2014; 41(4): 594-604.[CrossRef]
[32] Singh SK, Verma PRP, Razdan B. Development and characterization of a carvedilol-loaded self-microemulsifying delivery system. Clin Res Regul Aff. 2009; 26(3): 50-64. [CrossRef]
[33] Basalious EB, Shawky N, Badr-eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm. 2010; 391(1-2): 203-211. [CrossRef]